(LOSS) PER SHARE (Tables)

9 Months Ended

Sep. 30, 2024

Schedule of Calculation of Earnings (Loss) Per Share

Calculation of (loss) per share:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share amounts)	2024		2023		2024		2023
Net (loss)	$	(14,390)	$	(7,279)	$	(19,901)	$	(74,857)
Weighted-average common shares outstanding	85,625		83,336		85,018		82,996
(Loss) per share, basic	$	(0.17)	$	(0.09)	$	(0.23)	$	(0.90)

Net (loss)	$	(14,390)	$	(7,279)	$	(19,901)	$	(74,857)







Weighted-average common shares outstanding, assuming dilution (1) (2) (3)	85,625		83,336		85,018		82,996
(Loss) per share, diluted	$	(0.17)	$	(0.09)	$	(0.23)	$	(0.90)

Outstanding anti-dilutive stock options and RSUs (4)	4,528		2,255		3,682		1,652

(1) All dilutive securities are excluded when their inclusion would be anti-dilutive.

(2) The shares underlying the conversion options in the Company’s Notes are included using the if-converted method, if dilutive in the period. If the outstanding conversion options were fully exercised, the Company would issue approximately 3.7 million shares as of September 30, 2024.

(3) The Company’s Capped Call Transactions represent the equivalent of approximately 3.7 million shares of the Company’s common stock (representing the number of shares for which the Notes are convertible) as of September 30, 2024. The Capped Call Transactions are expected to reduce common stock dilution and/or offset any potential cash payments the Company must make, other than for principal and interest, upon conversion of the Notes, with such reduction and/or offset subject to a cap of $196.44. The Capped Call Transactions are excluded from weighted-average common shares outstanding, assuming dilution, in all periods as their effect would be anti-dilutive.

(4) Outstanding stock options and RSUs that were anti-dilutive under the treasury stock method in the period were excluded from the computation of diluted (loss) per share. These awards may be dilutive in the future.